The roller coaster ride to the first GLP-1 obesity drug While approved first as a drug for diabetes, very early on in its development, when Knudsen first began work on liraglutide she wondered if the same drug could also be used as a treatment of obesity (Molteni, Chen)
We don't have evidence of that yet
Further, compared to the Saxenda, the Wegovy offers more than 50% greater weight loss on average, with the typical patient losing 15% of their body weight (34 pounds)
So this is why when people are on larger doses, they can stop eating altogether
Compounded Semaglutide Tablets A once-daily oral tablet taken before food, beverages, and other oral medications
Customers who purchase Retatrutide as part of a broader Peptides / GLP-1 products strategy benefit from consolidated sourcing and reduced operational risk